19 / 22
Notes:
Volume 2, Issue 2 (Suppl)
Chronic Obstructive Pulmonary Diseases
ISSN: 2572-5548
Page 41
conferenceseries
.com
CO-ORGANIZED EVENT
August 31-September 01, 2017 Brussels, Belgium
&
International Conference on
Chronic Diseases
6
th
International Conference on
Microbial Physiology and Genomics
The lymphedemas as chronic diseases
Pierre Bourgeois
Université Libre de Bruxelles, Belgium
L
ymphedemas (LE) are edemas demonstrated as of lymphatic origin and LE may be observed at the level of any part of the
human body. In occidental and northern countries, these LE are usually secondary and related to surgeries and/or radiation
therapy for cancer (for instance, around 20% of the women after complete axillary node dissection for breast cancer). In tropics
worldwide and in Southeast Asia, this LE may be secondary to infection by filarial parasites (40 million people). Everywhere,
some LE may also be primary (10% of these 1ary LE are inherited and with provable genetic abnormalities). The incidence of
this 1ary LE is usually reported to be low but might be (largely) under-estimated. Anyway, these clinical situations represent
chronic diseases, also sometimes very heavy and disabling. There are no medical treatments (except in infectious diseases) and
although some surgical approaches begin to be proposed, the treatment of these situations remains mainly based on physical
therapies combining manual lymphatic drainages, therapeutic multi-layer bandagings, the use of pneumatic compression
systems. These treatments will however last the patients’ whole-life. In-between short intensive therapies, maintenance
therapeutic interventions are usually necessary as well as the wearing of elastic sleeves and/or stockings. Finally, one of the most
frequent thinking from people faced to secondary LE is rather prevent them than to have to try to cure them. These situations
are also unfortunately and poorly understood by people who try to treat these situations. The examinations however exist such
as the functional and morphologic lymphoscintigraphy investigations. The doctors ignore them and/or do not use their results
correctly. The patients themselves are also sometimes reluctant to undergo the proposed examinations although, when these
investigations and their implications are well explained, they are usually compliant. Lymphedemas represent chronic diseases
but they can be improved.
Biography
Pierre Bourgeois is a Specialist in Nuclear Medicine and in Radio-radium-therapy. He performed his first investigations of the lymphatic system in 1978. He is Head
of Clinic in the Service of Nuclear Medicine of the Jules Bordet’s Institute, also In-charge of Multi-disciplinary Clinic of Lymphology of the Institute. He is weekly in
contact with patients consulting him for edematous situations and is working with physiotherapists and surgeons involved in the management and treatments of
these patients. He was past-President of the European Society of Lymphology and is now President of the Belgian Society of Lymphology (BeSL).
pierre.bourgeois@bordet.bePierre Bourgeois, Chron Obstruct Pulmon Dis 2017, 2:2
DOI: 10.21767/2572-5548-C1-002